A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension.
- Resource Type
- journal article
- Source
- Medicine; 8/7/2020, Vol. 99 Issue 32, p1-12, 12p
- Subject
- Language
- ISSN
- 00257974